feed,title,long_url,short_url
r/covid19:2+,"[Preprint] Immunogenicity and safety of a third dose, and immune persistence of CoronaVac vaccine in healthy adults aged 18-59 years: interim results from a double-blind, randomized, placebo-controlled phase 2 clinical trial",https://redd.it/osfevr,
